0001127602-15-007937.txt : 20150224 0001127602-15-007937.hdr.sgml : 20150224 20150224162310 ACCESSION NUMBER: 0001127602-15-007937 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150220 FILED AS OF DATE: 20150224 DATE AS OF CHANGE: 20150224 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARIAD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000884731 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 223106987 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 26 LANDSDOWNE ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6174940400 MAIL ADDRESS: STREET 1: 26 LANDSDOWNE CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CLACKSON TIMOTHY P CENTRAL INDEX KEY: 0001242992 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36172 FILM NUMBER: 15643770 MAIL ADDRESS: STREET 1: C/O ARIAD PHARMACEUTICALS INC STREET 2: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2015-02-20 0000884731 ARIAD PHARMACEUTICALS INC ARIA 0001242992 CLACKSON TIMOTHY P C/O ARIAD PHARMACEUTICALS INC 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 1 President, R&D, CSO Common Stock 2015-02-20 4 M 0 24999 2.62 A 453231 D Common Stock 2015-02-20 4 S 0 24999 8.00 D 428232 D Common Stock 2015-02-20 4 M 0 24036 4.49 A 452268 D Common Stock 2015-02-20 4 S 0 24036 8.00 D 428232 D Employee Stock Option (Right to Buy) 2.62 2015-02-20 4 M 0 24999 0 D 2009-12-08 2019-12-08 Common Stock 24999 0 D Employee Stock Option (Right to Buy) 4.49 2015-02-20 4 M 0 24036 0 D 2008-04-16 2017-04-16 Common Stock 24036 31422 D Shares were acquired upon the exercise of outstanding stock options at $2.62 per share. This sale was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person in June 2014. Shares were acquired upon the exercise of outstanding stock options at $4.49 per share. /s/Edward M. Fitzgerald, Attorney-in-Fact 2015-02-23